ISUS:LSE:LSE-iShares MSCI USA Islamic UCITS (GBX)

ETF | Others |

Last Closing

USD 5516.5

Change

+173.00 (+3.24)%

Market Cap

USD 0.22B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+14.55 (+7.57%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.16 (+0.83%)

USD 640.06B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.24 (+1.67%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

+5.73 (+4.93%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
PRJU:LSE Amundi Index Solutions - Amund..

+0.32 (+1.01%)

USD 269.13B
0QZK:LSE Coca-Cola Co.

-1.90 (-2.67%)

USD 266.08B
0QZO:LSE 0QZO

+4.80 (+4.55%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

+7.20 (+4.95%)

USD 202.26B
0R24:LSE Intel Corp.

+1.05 (+5.01%)

USD 196.14B

ETFs Containing ISUS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.28% 15% F 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.28% 15% F 25% F
Trailing 12 Months  
Capital Gain -1.33% 23% F 39% F
Dividend Return 0.01% 6% D- 3% F
Total Return -1.32% 21% F 37% F
Trailing 5 Years  
Capital Gain 64.48% 57% F 65% D
Dividend Return 0.08% 6% D- 12% F
Total Return 64.56% 53% F 63% D
Average Annual (5 Year Horizon)  
Capital Gain 11.64% 73% C 74% C
Dividend Return 11.71% 72% C 74% C
Total Return 0.07% 35% F 29% F
Risk Return Profile  
Volatility (Standard Deviation) 8.32% 70% C- 84% B
Risk Adjusted Return 140.82% 99% N/A 99% N/A
Market Capitalization 0.22B 61% D- 35% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.